Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
20/10/2020 Product Information Update- Monover and Diafer (iron isomaltoside 1000/ ferric derisomaltose) 3rd Party Publications
15/10/2020 HPRA MIMS Article October 2020 3rd Party Publications
14/10/2020 Medicinal Product Shortages - update - 14 October 2020 Advisory
07/10/2020 Medicinal Product Shortages - update - 7 October 2020 Advisory
02/10/2020 Various Abstral Products — Caution-in-use notification (CIUN) Warning
30/09/2020 Medicinal Product Shortages - update - 30 September 2020 Advisory
23/09/2020 Medicinal Product Shortages - update - 23 September 2020 Advisory
16/09/2020 Medicinal Product Shortages - update - 16 September 2020 Advisory
14/09/2020 HPRA IMF Article September 2020 3rd Party Publications
09/09/2020 Medicinal Product Shortages - update - 09 September 2020 Advisory